Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62,500,000
-
Total 13F shares
-
23,135,999
-
Share change
-
+22,215,063
-
Total reported value
-
$610,407,430
-
Price per share
-
$26.49
-
Number of holders
-
68
-
Value change
-
+$586,012,654
-
Number of buys
-
66
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q2 2015
As of 30 Jun 2015,
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,135,999 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, Visium Asset Management, LP, RA CAPITAL MANAGEMENT, LLC, Partner Fund Management, L.P., LORD, ABBETT & CO. LLC, Citadel Advisors LLC, and DRIEHAUS CAPITAL MANAGEMENT LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.